Arne van Schanke, PhD

Arne van Schanke is Director, Early Development, Certara Drug Development Solutions. Dr. Van Schanke has two decades of experience working in the pharmaceutical industry at MSD and Certara. He obtained his PhD in veterinary medicine/toxicology from Utrecht University, Netherlands. He is a pragmatic biomedical scientist who evolved from biochemical interactions and cancer research into drug metabolism and pharmacokinetics expert and translational modeler working in a broad array of indications including Oncology, Virology, Fertility, Immunology, and Inflammation.